🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06983275
Recruiting Not applicable

Exploration of the Effectiveness of Vibrational Intervention in Improving Insomnia Symptoms

NCT06983275 · tracked via the Priya Life Science China tracker
Sponsor
Jia Xiu
Phase
Not applicable
Started
2025-09-01
Last updated
2025-09-19

Condition(s) studied

Chronic Insomnia

Investigational drug(s) / intervention(s)

Vibrational stimulationSham

Vibrational stimulation: Fifteen minutes before bedtime, participants will wear a vibration stimulation device on the forehead while lying down in a comfortable position. The stimulation intensity will be set to 60% of the device's maximum output. Participants will receive a 15-minute session of 40 Hz vibration stimulation with a 50% duty cycle: 15 seconds of stimulation followed by 15 seconds of rest, repeated continuously. After the session, participants will remove the device and prepare for sleep immediately.

Sham: Fifteen minutes before bedtime, participants will lie down in a comfortable position and listen to the 40 Hz noise generated by the vibration device (without receiving actual vibration). After the session, they will remove the device and prepare for sleep immediately.

Study summary

Study Purpose The purpose of this clinical trial is to investigate whether low-intensity frontal vibration can improve sleep performance in individuals with chronic insomnia. Additionally, the study aims to explore its potential effects on memory enhancement.

The primary objectives of the study are to address the following questions:

* Does low-intensity frontal vibration improve sleep performance in patients with chronic insomnia?
* Does low-intensity frontal vibration enhance memory performance in patients with chronic insomnia?

Researchers will compare the effects of low-intensity frontal vibration with a sham stimulation (in which participants hear only noise associated with the vibration process) to determine whether the active intervention can effectively improve symptoms of chronic insomnia.

Participant Involvement

Participants in the study will:

* Record daily sleep diaries via a mobile application for a total of 9 weeks
* Receive daily intervention during a 4-week intervention phase as scheduled by the study
* Complete weekly self-reported sleep questionnaires through the app
* Undergo memory performance assessments at the beginning and end of the study

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Aged 18 to 65 years, regardless of gender; * Diagnosed with chronic insomnia disorder according to DSM-5 criteria, with a primary complaint of difficulty falling asleep (sleep onset latency \> 30 minutes), occurring ≥3 times per week, lasting for more than 3 months but less than 3 years; * Able to independently operate a smartphone, and capable of completing self-reported assessments and applying the self-administered intervention after instruction. Exclusion Criteria: * Presence of sleep disorders such as sleep apnea syndrome or restless legs syndrome; * Epworth Sleepiness Scale (ESS) score \> 10; * Use of any sleep-related medication within the past month; * Patient Health Questionnaire-9 (PHQ-9) score \> 15 or Generalized Anxiety Disorder-7 (GAD-7) score \> 10; * Currently participating in any form of cognitive behavioral therapy or neuromodulation intervention study; * Working night shifts or rotating shifts; * Clinically diagnosed neurological disorders such as epilepsy, stroke, dementia, or Parkinson's disease, or psychiatric disorders such as bipolar disorder, obsessive-compulsive disorder, phobias, or panic disorder; * Substance abuse (including alcohol or drugs), defined as more than 14 drinks/week for males or 12 drinks/week for females.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Fudan University Shanghai Shanghai Municipality Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06983275 on ClinicalTrials.gov ↗ ← All trials in China